Clearmind Medicine Inc.

Historical 13F Holders

Symbol
CMND
CUSIP
185053402
All holders as of
Q3 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 185053402 since 12/18/2024, newest first.

Filer % of Class Filed
L.I.A. Pure Capital Ltd 13G/A Amendment 3 0% 5/15/2026
Event 3/31/2026
Capitalink Ltd. 13G/A Amendment 3 0% 5/15/2026
Event 3/31/2026
L.I.A. Pure Capital Ltd 13G/A Amendment 2 5.0%
Checked 5% or less
3/16/2026
Event 2/9/2026
Capitalink Ltd. 13G/A Amendment 2 5.0%
Checked 5% or less
3/16/2026
Event 2/9/2026
Nissim Daniel 13G/A Amendment 1 0% 3/9/2026
Event 12/31/2025
L.I.A. Pure Capital Ltd 13G/A Amendment 1 10.0% 12/10/2025
Event 12/3/2025
Capitalink Ltd. 13G/A Amendment 1 10.0% 12/10/2025
Event 12/3/2025
Capitalink Ltd. 13G 10.0% 12/1/2025
Event 11/19/2025
L.I.A. Pure Capital Ltd 13G 10.0% 12/1/2025
Event 11/19/2025
Nissim Daniel 13G 10.0% 11/28/2025
Event 11/19/2025
Iroquois Capital Management, LLC 13G/A Amendment 3
9.9% 11/18/2025
Event 9/30/2025
AdvisorShares Trust 13G/A Amendment 1 4.8% 7/3/2025
Event 6/30/2025
Iroquois Capital Management, LLC 13G/A Amendment 2
6.2% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 7 281 k $288 k
2025 Q2 10 590 k $5.51 M
2025 Q1 8 602 k $5.45 M
2024 Q4 10 613 k $5.49 M
2024 Q3 9 702 k $5.49 M
2024 Q2 5 166 k $276 k
2024 Q1 5 153 k $175 k
2023 Q4 2 92.7 k $260 k